From: Epidemiology of childhood and adolescent cancer in Bangladesh, 2001–2014
Period of diagnosis | |||||||
---|---|---|---|---|---|---|---|
2007–2010 | 2011–2014 | ||||||
ICCC diagnostic group | N | % | Ratea | N | % | Ratea | M:F ratio |
Total | 93 | 1.5 | 133 | 2.1 | 1.4:1 | ||
I Leukaemia | 3 | 3.2 | 0.05 | 6 | 4.5 | 0.09 | 5.0:1 |
ALL | 2 | 6 | |||||
AML | 1 | – | |||||
II Lymphoma | 38 | 40.9 | 0.6 | 7 | 5.3 | 0.1 | 1.3:1 |
Hodgkin lymphoma | 13 | 2 | |||||
Non-Hodgkin lymphoma | 25 | 4 | |||||
III CNS tumours | 1 | 1.1 | 0.02 | 10 | 7.5 | 0.2 | 2.3:1 |
Ependymoma | – | – | |||||
Astrocytoma | – | 3 | |||||
Medulloblastoma | – | 5 | |||||
IV Neuroblastoma | – | – | – | – | – | – | – |
V Retinoblastoma | 1 | 1.1 | 0.02 | 2 | 1.5 | 0.03 | – |
VI Renal tumours | 3 | 3.2 | 0.05 | – | – | – | – |
Nephroblastoma | 3 | – | |||||
VII Hepatic tumours | – | – | – | 1 | 0.8 | 0.02 | – |
Hepatoblastoma | – | 1 | |||||
VIII Bone tumours | 18 | 19.4 | 0.3 | 50 | 37.6 | 0.8 | 1.9:1 |
Osteosarcoma | 13 | 34 | |||||
Chondrosarcoma | – | 1 | |||||
Ewing tumour | 5 | 15 | |||||
IX Soft tissue sarcomas | 6 | 6.5 | 0.1 | 11 | 8.3 | 0.2 | 0.6:1 |
Rhabdomyosarcoma | 5 | 6 | |||||
Fibrosarcoma | – | 2 | |||||
X Germ cell and gonadal tumours | 14 | 15.1 | 0.2 | 22 | 16.5 | 0.4 | 0.4:1 |
XI Other epithelial tumours | 7 | 7.5 | 0.1 | 21 | 15.8 | 0.3 | 4.3:1 |
Nasopharyngeal carcinoma | 4 | 1 | |||||
XII Other and unspecified tumours | 2 | 2.2 | 0.03 | 3 | 2.3 | 0.05 | 0.5:1 |